A novel variant in BCL11B in an individual with neurodevelopmental delay: A case report

Mol Genet Genomic Med. 2023 Apr;11(4):e2132. doi: 10.1002/mgg3.2132. Epub 2023 Jan 23.

Abstract

Background: B-Cell CLL/Lymphoma 11B (BCL11B) is a C2 H2 zinc finger transcription factor that has broad biological functions and is essential for the development of the immune system, neural system, cardiovascular system, dermis, and dentition. Variants of BCL11B have been found in patients with neurodevelopmental disorders and immunodeficiency.

Materials and methods: Whole-exome sequencing (WES) and clinical examinations were performed to identify the etiology of our patient. A variant in the BCL11B gene, NM_138576.4: c.1206delG (p.Phe403Serfs*2) was found and led to frameshift truncation.

Results: We reported a male patient with developmental delay and cerebral palsy who carried the BCL11B variant. The detailed clinical features, such as brain structure and immune detection, were described and reviewed in comparison to previous patients.

Conclusions: The BCL11B-related neurodevelopmental disorders are rare, and only 17 variants in 25 patients have been found to date. Our report expands the variants spectrum of BCL11B and increases the case of neurodevelopmental abnormalities.

Keywords: BCL11B; cerebral palsy; developmental delay; whole-exome sequencing.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain / diagnostic imaging
  • Cerebral Palsy* / diagnostic imaging
  • Cerebral Palsy* / genetics
  • Child, Preschool
  • Developmental Disabilities* / diagnostic imaging
  • Developmental Disabilities* / genetics
  • Exome Sequencing
  • Genetic Variation*
  • Humans
  • Male
  • Repressor Proteins* / genetics
  • Tumor Suppressor Proteins* / genetics

Substances

  • BCL11B protein, human
  • Repressor Proteins
  • Tumor Suppressor Proteins